5-HT 2a antagonists (Merck & Co)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Name5-HT 2a antagonists (Merck & Co)
Drug Alias Name5-HT 2a antagonists (MSD)2-phenylindoles (Merck)L-838913L-802387L-838751 +[6] 
ClassificationSmall molecules
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsSchizophreniaSleep Initiation and Maintenance Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme Ltd
Active IndicationsN/A
Inactive IndicationsSchizophreniaSleep Initiation and Maintenance Disorders

Other Information

ATC CodeN/A
Related LinksN/A